文献信息 RETRACTED

Emodin promotes the arrest of human lymphoma Raji cell proliferation through the UHRF1‑DNMT3A‑∆Np73 pathways

期刊 Molecular medicine reports
发表日期 2017-Nov
作者 Lin Yun; Chen Weiming; Wang Zhihong; Cai Pengwei
DOI 10.3892/mmr.2017.7423
PMID 28901428
原始摘要

Emodin is an active constituent found in the roots and rhizomes of numerous Chinese medicinal herbs. It exerts antitumor activity against Dalton's lymphoma in vivo, although the detailed mechanisms by which emodin induces apoptosis remains to be elucidated. The present study aimed to analyze the mechanisms underlying the response to emodin treatment. Using lymphoma Raji cells, an emodin‑induced cell proliferating inhibition model was first established, then flow cytometry, western blotting, reverse transcription‑quantitative polymerase chain reaction and luciferase reporter assay were performed. It was found that emodin decreased the percentage of Raji cell viability, induced apoptosis, and increased the activation of caspase 3, caspase 9 and poly (ADP‑ribose) polymerase through the downregulation of ubiquitin‑like protein containing PHD and RING domains 1 (UHRF1). The emodin‑induced downregulation of UHRF1 led to an increase in the level of DNA methyltransferase 3A, which in turn inhibited the activity of p73 promoter 2 and decreased the levels of NH2‑terminally truncated dominant‑negative p73. The treatment of Raji cells with emodin combined with doxorubicin led increased cell death of Raji cells, indicating that emodin may sensitize Raji cells to doxorubicin‑induced apoptosis.

撤稿信息
撤稿日期 2026-Sep
撤稿期刊 Molecular medicine reports
发布机构 Greece
通知PMID 42495751
撤稿通知标题:
[Retracted] Emodin promotes the arrest of human lymphoma Raji cell proliferation through the UHRF1‑DNMT3A‑∆Np73 pathways
AI 提取信息
研究领域
基础医学
文章类型
原创研究(Original Research)
研究方法
体外细胞实验
疾病/条件
淋巴瘤
数据来源
实验室自产(Lab-generated)
撤稿原因
图像篡改(Image Manipulation/Duplication)
撤稿类型
撤稿(Full Retraction)
研究机构
Department of Hematology, Fujian Provincial Hospital, Provincial Clinical Medical College of Fujian Medical University, Fuzhou, Fujian 350108, P.R. China; Department of Clinical Laboratory, Fujian Provincial Hospital, Provincial Clinical Medical College of Fujian Medical University, Fuzhou, Fujian 350108, P.R. China
国家/地区
中国
资助来源
未提及
返回文献列表
回到顶部